Abstract
Background
Intraoperative parathyroid hormone (IOPTH) monitoring is crucial in the treatment of primary hyperparathyroidism (PHPT). Often, the 5 min IOPTH levels fall, but not by the requisite 50 %. In such cases, the surgeon must decide whether to wait for additional levels or to continue exploration. This study aimed to evaluate the 5 min drop in IOPTH for distinguishing single adenomas (SA) from multigland disease.
Methods
A retrospective analysis of a prospectively collected database was performed on PHPT patients who underwent initial curative parathyroidectomy between 2001 and 2013. Those with familial disease and those taking lithium or undergoing concomitant thyroidectomy were excluded from the analysis. For cases of double adenomas (DA) or hyperplasia (HA), the IOPTH values indicating additional glands were analyzed.
Results
The inclusion criteria were met by 1021 patients: 817 patients with SA (82.2 %), 99 patients with DA (10 %), and 78 with HA (7.9 %). The SA patients exhibited a 56.6 ± 4.9 % decline in IOPTH at 5 min compared with 21.3 ± 4.5 % of the DA patients and 22.5 ± 4.3 % of the HA patients (p < 0.01). Post hoc comparisons showed that the 5 min decrease in the SA group was significantly greater than in either the DA group or the HA group (p < 0.01). A 5 min percentage decline of 35 % best distinguished SA from multiglandular disease (85.3 vs. 24.9 %).
Conclusion
The data suggest that when IOPTH level does not drop by at least 35 % at 5 min after excision, the surgeon should consider further exploration rather than wait for additional levels.
Similar content being viewed by others
References
Palazzo FF, Delbridge LW. Minimal-access/minimally invasive parathyroidectomy for primary hyperparathyroidism. Surg Clin North Am. 2004;84:717–34.
Bergenfelz A, Lindblom P, Tibblin S, et al. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg. 2002;236:543–51.
Irvin GL III, Solorzano CC, Carneiro DM. Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg. 2004;28:1287–92.
Irvin GL III, Dembrow VD, Prudhomme DL. Clinical usefulness of an intraoperative “quick parathyroid hormone” assay. Surgery. 1993;114:1019–22.
Schneider DF, Mazeh H, Sippel RS, Chen H. Is minimally invasive parathyroidectomy associated with greater recurrence compared to bilateral exploration? Analysis of more than 1000 cases. Surgery. 2012;152:1008–15.
Mazeh H, Chen H, Leverson G, et al. Creation of a “Wisconsin index” nomogram to predict the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomy. Ann Surg. 2013;257:138–41.
Cook M, Pitt S, Schaefer S, et al. A rising IOPTH level immediately after parathyroid resection are additional hyperfunctioning glands always present? An application of the Wisconsin criteria. Ann Surg. 2010;252:1127–30.
Burkey SH, Van Heerden JA, Farley DR, et al. Will directed parathyroidectomy utilizing the gamma probe or intraoperative parathyroid hormone assay replace bilateral cervical exploration as the preferred operation for primary hyperparathyroidism? World J Surg. 2002;26:914–20.
Goldstein RE, Carter WM II, Fleming M, et al. Unilateral cervical surgical exploration aided by intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism and equivocal sestamibi scan results. Arch Surg. 2006;141:552–7.
Chen H, Pruhs Z, Starling JR, et al. Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery. 2005;138:583–7.
Chen H, Mack E, Starling JR. A comprehensive evaluation of perioperative adjuncts during minimally invasive parathyroidectomy: which is most reliable? Ann Surg. 2005;242:375–80.
Karakousis GC, Han D, Kelz RR, et al. Interpretation of intraoperative PTH changes in patients with multiglandular primary hyperparathyroidism (pHPT). Surgery. 2007;142:845–50.
Ollila DW, Caudle AS, Cance WG, et al. Successful minimally invasive parathyroidectomy for primary hyperparathyroidism without using intraoperative parathyroid hormone assays. Am J Surg. 2006;191:52–6.
Stalberg P, Sidhu S, Sywak M, et al. Intraoperative parathyroid hormone measurement during minimally invasive parathyroidectomy: does it “value-add” to decision making? J Am Coll Surg. 2006;203:1–6.
Stratmann SL, Kuhn JA, Bell MS, et al. Comparison of quick parathyroid assay for uniglandular and multiglandular parathyroid disease. Am J Surg. 2002;184(6):578–81.
Irvin G, Carneiro D. Rapid parathyroid hormone assay-guided exploration. Oper Tech Gen Surg. 1999;1:10–28.
Irvin G, Prudhomme D, Deriso G, et al. A new approach to parathyroidectomy. Ann Surg. 1994;219:574–9.
Chen H, Sokoll LJ, Udelsman R. Outpatient minimally invasive parathyroidectomy: a combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay. Surgery. 1999;126:1016–21.
Gauger PG, Agarwal G, England BG, et al. Intraoperative parathyroid hormone monitoring fails to detect double parathyroid adenomas: a 2-institution experience. Surgery. 2001;130:1005–10.
Haciyanli M, Lal G, Morita E, et al. Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma. J Am Coll Surg. 2003;197:739–46.
Gill MT, Dean M, Karr J, et al. Intraoperative parathyroid hormone assay: a necessary tool for multiglandular disease. Otolaryngol Head Neck Surg. 2011;144:691–7.
Weber KJ, Misra S, Lee JK, et al. Intraoperative PTH monitoring in parathyroid hyperplasia requires stricter criteria for success. Surgery. 2004;136:1154–9.
Miller BS, England BG, Nehs M, et al. Interpretation of intraoperative parathyroid hormone monitoring in patients with baseline parathyroid hormone levels of <100 pg/mL. Surgery. 2006;140:883–9.
Kandil E, Alabbas HH, Bansal A, et al. Intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma. Arch Otolaryngol Head Neck Surg. 2009;135:1206–8.
Stepaniak PS, Vrijland WW, de Quelerij M, de Vries G, Heij C. Working with a fixed operating room team on consecutive similar cases and the effect on case duration and turnover time. Arch Surg. 2010;145:1165–70.
Dexter F, Coffin S, Tinker JH. Decreases in anesthesia-controlled time cannot permit one additional surgical operation to be reliably scheduled during the workday. Anesth Analg. 1995;81:1263–8.
Cendán JC, Good M. Interdisciplinary work flow assessment and redesign decreases operating room turnover time and allows for additional caseload. Arch Surg. 2006;141:65–9.
Park KW, Dickerson C. Can efficient supply management in the operating room save millions? Curr Opin Anesth. 2009;22:242–8.
Dexter F, Abouleish AE, Epstein RH, Whitten CW, Lubarsky DA. Use of operating room information system data to predict the impact of reducing turnover times on staffing costs. Anesth Analg. 2003;97:1119–26.
Libutti SK, Alexander HR, Bartlett DL, et al. Kinetic analysis of the rapid intraoperative parathyroid hormone assay in patients during operation for hyperparathyroidism. Surgery. 1999;126:1145–50.
Acknowledgment
This study was supported by NIH Grants UL1TR000427 and KL2TR000428. The ministry of higher education of Saudi Arabia, and a KFSH&RC, Riyadh, Saudi Arabia scholarship for Alhefdhi provided fellowship and financial support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
All authors have nothing to disclose.
Rights and permissions
About this article
Cite this article
Alhefdhi, A., Ahmad, K., Sippel, R. et al. Intraoperative Parathyroid Hormone Levels at 5 min Can Identify Multigland Disease. Ann Surg Oncol 24, 733–738 (2017). https://doi.org/10.1245/s10434-016-5617-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-016-5617-1